Ito M, Baba M, Sato A, Pauwels R, De Clercq E, Shigeta S
Department of Bacteriology, Fukushima Medical College, Japan.
Antiviral Res. 1987 Jul;7(6):361-7. doi: 10.1016/0166-3542(87)90018-0.
The polyanionic substances dextran sulfate and heparin were investigated for their antiviral effect on the human immunodeficiency virus (HIV) in vitro. Dextran sulfate and heparin effected a 50% reduction in the cytopathogenicity of HIV for MT-4 cells at a concentration of 4.7 and 7.5 micrograms/ml, respectively. In Molt-4 (clone 8) cells, these values were slightly higher (14.1 and 15.6 micrograms/ml, respectively). No toxicity for the host cells was noted with these compounds at a concentration up to 400 micrograms/ml, so that the selectivity indexes, as based on the ratio of the 50% cytotoxic dose to the 50% antiviral effective dose, were well in excess of 100. These findings may have far reaching implications both diagnostically, when attempts are made to isolate HIV from heparinized blood samples, as therapeutically, to the extent that dextran sulfate or heparin may be useful in blocking HIV replication in vivo.
研究了聚阴离子物质硫酸葡聚糖和肝素在体外对人类免疫缺陷病毒(HIV)的抗病毒作用。硫酸葡聚糖和肝素分别在浓度为4.7微克/毫升和7.5微克/毫升时,使HIV对MT - 4细胞的细胞病变效应降低50%。在Molt - 4(克隆8)细胞中,这些值略高(分别为14.1微克/毫升和15.6微克/毫升)。在浓度高达400微克/毫升时,未观察到这些化合物对宿主细胞有毒性,因此,基于50%细胞毒性剂量与50%抗病毒有效剂量之比的选择性指数远超过100。这些发现可能在诊断方面具有深远意义,即在试图从肝素化血液样本中分离HIV时,以及在治疗方面,就硫酸葡聚糖或肝素可能有助于体内阻断HIV复制而言。